Sales and Marketing

Showing 15 posts of 11527 posts found.

Pharma thumbs-up for government innovation centre

September 12, 2012 Research and Development, Sales and Marketing ABPI, synthetic biology

The announcement of a new innovation and knowledge centre for synthetic biology has been welcomed by pharma groups.The new centre is part …

New frontiers in drug discovery

September 11, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing RNA, drug discovery, therapeutic

Despite the success of small molecule and biologic drugs such as monoclonal antibodies, there remain many areas of unmet medical …

Circassia appoints GSK’s Dr Brett Haumann

September 11, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Brett Haumann, Circassia

Speciality biopharma firm Circassia has announced the appointment of Dr Brett Haumann as chief medical officer. Haumann joins allergy-focussed Circassia …

Merck releases new Phase III insomnia data

September 11, 2012 Research and Development, Sales and Marketing Merck, insomnia, suvorexant

Merck says it is on course to file its investigational insomnia drug suvorexant in the US by the end of …

Rock appoints new associate director

September 11, 2012 Business Services, Medical Communications, Sales and Marketing Laura Patel, Rock Medical Communications

ROCK medical communications has appointed Laura Patel as associate director. Patel has considerable experience in managing key medical education programmes, …

MedImmune signs China deal

September 11, 2012 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, China, MedImmune, WuXi, emerging markets, rheumatoid arthritis

MedImmune has sealed a joint venture with Shanghai-based WuXi AppTec to develop a novel biologic for autoimmune and inflammatory diseases …

Ex-Pfizer head joins Red Door as International director

September 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Thomas, Pfizer, Red Door

Andrew Thomas the strategic communications lead for Pfizer’s primary care medicines across Europe and Canada joins Red Door Communications in …

Lilly suffers late-stage cancer blow

September 10, 2012 Research and Development, Sales and Marketing Alimta, Cancer, avastin, lilly, oncology

Eli Lilly suffered a blow to its oncology programme when a new combination treatment failed to improve overall survival in …

Merck KGaA licences new cancer candidate

September 10, 2012 Research and Development, Sales and Marketing Cancer, EGFR, Merck KGaA, oncology

Merck KGaA has signed a worldwide licence agreement with Danish company Symphogen which could expand its portfolio of drugs targeting …

Kantar appoints Graeme Jacombs head of APMEA region

September 7, 2012 Sales and Marketing Kantar Health

Consultancy and market research firm Kantar Health has promoted Graeme Jacombs to Managing Director of the Asia Pacific, Middle East …

Boehringer signs diabetes research deal

September 7, 2012 Sales and Marketing Boehringer, diabetes, obesity

Boehringer Ingelheim has signed a four-year research agreement with a top Swiss university to look at the underlying causes of …

New product launches – maximise your chance of success

September 6, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, Paul Stuart Kregor, Paul Stuart-Kregor, marketing, product launch

You don’t have to look very far to see that the pharma industry business model is under increased pressure, and …

Double approval for Pfizer cancer drugs

September 6, 2012 Sales and Marketing CML, Cancer, Glivec, Pfizer, axitinib, rcc

 Two cancer drugs from Pfizer have been approved, one in Europe for kidney cancer and another in the US for …

Pharma welcomes Hunt to top health job

September 5, 2012 Research and Development, Sales and Marketing Andrew Lansley, NHS, NHS reform

The ABPI has used health secretary Andrew Lansley’s demotion at prime minister David Cameron’s first major cabinet reshuffle to restate …

Pfizer to develop phase II cancer vaccine

September 4, 2012 Research and Development, Sales and Marketing Cancer, Pfizer, VLST, cancer vaccine

Pfizer has licensed a cancer compound which is ready for phase II study from a US firm specialising in cancer …
The Gateway to Local Adoption Series

Latest content